NASH and Fibroscan | Raj Vuppalanchi, MD

International Workshop on NASH Biomarkers 2016

Early-treated infants living with hiv typically recover their CD4+ T-cell counts but not their CD4+ T-cell percentages

International Workshop on HIV Pediatrics 2021

Social Determinants of Peripartum Depressive Symptoms Among Black Peripartum Women Living With HIV

International Workshop on HIV & Women 2021

Resistance to INSTIs and How Resistance Impacts Treatment Choices - Charles Boucher, MD, PhD

Salvador HIV Clinical Forum 2019

Integrase Inhibitors in ART Regimens in Patients with Co-Infection - A.V. Kravchenko, DMC

Russian HIV Clinical Forum 2019

Practical Guidance Diabetes management - Introductory Talk -- Beatriz Gonzalez, MD

European Workshop on NASH in Clinical Practice 2019

Pharmacokinetic and virological efficacy of dolutegravir (50 mg BID) containing regimen in association with rifampin in HIV-infected patients using Dried Blood Spot: ANRS-12313 NAMSAL sub-study in Cameroon- Le

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018

Mutations to Integrase inhibitors in real life- Dr. Isabel Viciana Ramos

Global HIV Clinical Forum 2017

O_13: CYP3A induction data can predict other P450 and drug transporter DDI liability: An example of carbamazepine and rifabutin with sofosbuvir and P-gp- Brian Kirby, MD

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Long acting (LA) drug delivery in TB treatment | Andrew Owen, BSS, MSC, PhD, FSB

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016